- Home
- CCEL vs CALC Comparison
CCEL vs CALC Comparison
Compare CCEL & CALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCEL
- CALC
- Stock Information
- Founded
- CCEL 1989
- CALC 2011
- Country
- CCEL United States
- CALC United States
- Employees
- CCEL N/A
- CALC N/A
- Industry
- CCEL Managed Health Care
- CALC Biotechnology: Pharmaceutical Preparations
- Sector
- CCEL Health Care
- CALC Health Care
- Exchange
- CCEL Nasdaq
- CALC Nasdaq
- Market Cap
- CCEL 50.0M
- CALC 40.3M
- IPO Year
- CCEL 1997
- CALC N/A
- Fundamental
- Price
- CCEL $7.79
- CALC $2.76
- Analyst Decision
- CCEL
- CALC Strong Buy
- Analyst Count
- CCEL 0
- CALC 5
- Target Price
- CCEL N/A
- CALC $18.20
- AVG Volume (30 Days)
- CCEL 12.4K
- CALC 69.1K
- Earning Date
- CCEL 12-31-2024
- CALC 11-13-2024
- Dividend Yield
- CCEL 3.17%
- CALC N/A
- EPS Growth
- CCEL N/A
- CALC N/A
- EPS
- CCEL N/A
- CALC N/A
- Revenue
- CCEL $31,838,476.00
- CALC N/A
- Revenue This Year
- CCEL $3.97
- CALC N/A
- Revenue Next Year
- CCEL $0.91
- CALC N/A
- P/E Ratio
- CCEL N/A
- CALC N/A
- Revenue Growth
- CCEL 1.95
- CALC N/A
- 52 Week Low
- CCEL $4.47
- CALC $2.05
- 52 Week High
- CCEL $9.50
- CALC $8.38
- Technical
- Relative Strength Index (RSI)
- CCEL 43.85
- CALC 34.02
- Support Level
- CCEL $7.60
- CALC $2.67
- Resistance Level
- CCEL $9.10
- CALC $2.90
- Average True Range (ATR)
- CCEL 0.25
- CALC 0.26
- MACD
- CCEL -0.14
- CALC 0.00
- Stochastic Oscillator
- CCEL 15.08
- CALC 50.35
About CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from cellular processing and cryogenic storage and it derives revenue from processing and testing fees and storage segment.
About CALC CalciMedica Inc.
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapies for life-threatening inflammatory diseases with high unmet need. Its proprietary technology targets the inhibition of calcium release-activated calcium channels designed to modulate the immune response and protect against tissue cell injury, with the potential to provide therapeutic benefits in life-threatening inflammatory diseases for which there are no approved therapies.